However, suppression of AGO2-1, COX7A1-2, and SLC26A3-1, could also have an opposite effect in NSCLC cells by upregulating the miRs, -25-5p, -30a-3p and -378, which act via MAPK/ERK, and are projected targets of these lncRNAs (Table 3), and have reduced anti-cancer efficacy when their expression is increased25,28,30. Here, COX7A1 is linked to non-small cell lung carcinoma.